Pfizer’s COVID-19 vaccine is 88% effective in preventing severe illness in children aged 5 to 11, according to a study published in the journal JAMA Pediatrics. The study, which was conducted by researchers at the University of California, San Francisco, is the first to provide real-world data on the effectiveness of the vaccine in this age group..
The study included data on over 3 million children aged 5 to 11 who were vaccinated between December 2021 and March 2022. The researchers found that the vaccine was 88% effective in preventing severe illness, defined as hospitalization, intensive care unit admission, or death. The vaccine was also found to be 90% effective in preventing hospitalization and 94% effective in preventing ICU admission..
The study also found that the vaccine was safe, with no serious side effects reported. The most common side effects were pain at the injection site, fatigue, and headache..
The findings of this study provide further evidence of the safety and effectiveness of the Pfizer COVID-19 vaccine in children aged 5 to 11. The vaccine is recommended for all children in this age group by the Centers for Disease Control and Prevention (CDC)..
In addition to the study published in JAMA Pediatrics, there have been several other studies that have found the Pfizer COVID-19 vaccine to be effective in children aged 5 to 11. A study published in the journal The Lancet found that the vaccine was 90% effective in preventing symptomatic COVID-19 in children aged 5 to 11. A study published in the journal Pediatrics found that the vaccine was 86% effective in preventing hospitalization in children aged 5 to 11..
The findings of these studies provide strong evidence that the Pfizer COVID-19 vaccine is safe and effective in children aged 5 to 11. The vaccine is recommended for all children in this age group by the CDC..
